Literature DB >> 12920624

Specific infectious complications after stem cell transplantation.

Holger Hebart1, Hermann Einsele.   

Abstract

Infectious complications continue to be a leading cause of morbidity and mortality after stem cell transplantation (SCT). The most important determinants for risk and outcomes are the stem cell source and the time after transplantation that the infection occurs. More recent developments in preparative regimens and graft manipulations, as well as the control of some important infectious complications after SCT by the introduction of effective prophylaxis and preemptive treatment strategies, have had a great impact on the timing and the epidemiology of infections posttransplantation. Better control of infectious complications posttransplantation has resulted in a reduced transplant-related mortality.

Entities:  

Mesh:

Year:  2003        PMID: 12920624     DOI: 10.1007/s00520-003-0511-3

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  34 in total

1.  Risk for cytomegalovirus disease in patients receiving polymerase chain reaction-based preemptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modality.

Authors:  H Hebart; W Brugger; U Grigoleit; B Gscheidle; J Loeffler; H Schäfer; L Kanz; H Einsele; C Sinzger
Journal:  Blood       Date:  2001-04-01       Impact factor: 22.113

2.  2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Authors:  Walter T Hughes; Donald Armstrong; Gerald P Bodey; Eric J Bow; Arthur E Brown; Thierry Calandra; Ronald Feld; Philip A Pizzo; Kenneth V I Rolston; Jerry L Shenep; Lowell S Young
Journal:  Clin Infect Dis       Date:  2002-02-13       Impact factor: 9.079

3.  Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products.

Authors:  W Garrett Nichols; Thomas H Price; Ted Gooley; Lawrence Corey; Michael Boeckh
Journal:  Blood       Date:  2003-01-16       Impact factor: 22.113

4.  Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening.

Authors:  H Hebart; J Löffler; C Meisner; F Serey; D Schmidt; A Böhme; H Martin; A Engel; D Bunje; W V Kern; U Schumacher; L Kanz; H Einsele
Journal:  J Infect Dis       Date:  2000-05-15       Impact factor: 5.226

5.  Detection and identification of fungal pathogens in blood by using molecular probes.

Authors:  H Einsele; H Hebart; G Roller; J Löffler; I Rothenhofer; C A Müller; R A Bowden; J van Burik; D Engelhard; L Kanz; U Schumacher
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

6.  Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells.

Authors:  A Gustafsson; V Levitsky; J Z Zou; T Frisan; T Dalianis; P Ljungman; O Ringden; J Winiarski; I Ernberg; M G Masucci
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

7.  Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease.

Authors:  Barbara C Gärtner; Hansjörg Schäfer; Katja Marggraff; Günter Eisele; Marco Schäfer; Dagmar Dilloo; Klaus Roemer; Hans-Jürgen Laws; Martina Sester; Urban Sester; Hermann Einsele; Nikolaus Mueller-Lantzsch
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

8.  Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients.

Authors:  Raoul Herbrecht; Valérie Letscher-Bru; Corina Oprea; Bruno Lioure; Jocelyn Waller; France Campos; Odile Villard; Kun-Lun Liu; Shanti Natarajan-Amé; Patrick Lutz; Patrick Dufour; Jean-Pierre Bergerat; Ermanno Candolfi
Journal:  J Clin Oncol       Date:  2002-04-01       Impact factor: 44.544

9.  Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Authors:  T J Walsh; R W Finberg; C Arndt; J Hiemenz; C Schwartz; D Bodensteiner; P Pappas; N Seibel; R N Greenberg; S Dummer; M Schuster; J S Holcenberg
Journal:  N Engl J Med       Date:  1999-03-11       Impact factor: 91.245

10.  Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies.

Authors:  Holger Hebart; Claudia Bollinger; Paul Fisch; Jacqueline Sarfati; Christoph Meisner; Manuela Baur; Jürgen Loeffler; Michel Monod; Jean-Paul Latgé; Hermann Einsele
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

View more
  4 in total

Review 1.  Haemopoietic stem cell transplantation for genetic disorders.

Authors:  C G Steward; A Jarisch
Journal:  Arch Dis Child       Date:  2005-12       Impact factor: 3.791

2.  Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies.

Authors:  Rodrigo Martino; Rocío Parody Porras; Nuria Rabella; John V Williams; Elena Rámila; Nuria Margall; Rosa Labeaga; James E Crowe; Pedro Coll; Jorge Sierra
Journal:  Biol Blood Marrow Transplant       Date:  2005-10       Impact factor: 5.742

3.  C-reactive protein levels before reduced-intensity conditioning predict outcome after allogeneic stem cell transplantation.

Authors:  Mats Remberger; Jonas Mattsson
Journal:  Int J Hematol       Date:  2010-06-25       Impact factor: 2.490

Review 4.  Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation.

Authors:  Theresa Kaeuferle; Ramona Krauss; Franziska Blaeschke; Semjon Willier; Tobias Feuchtinger
Journal:  J Hematol Oncol       Date:  2019-02-06       Impact factor: 17.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.